GBT launches ACCEL grants program to improve access to care for people with SCD
Global Blood Therapeutics announced the launch of the Access to Excellent Care for Sickle Cell Patients Pilot Program to provide grant funding to support novel projects aimed at improving access to high-quality healthcare for sickle cell patients in the U.S. February 19, 2019